marimastat has been researched along with Cancer of Ovary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| A'Hern, R; Gore, M; Slevin, M; Stankiewicz, M | 1 |
| McCann, PP; Rasmussen, HS | 1 |
| Neijt, JP | 1 |
2 review(s) available for marimastat and Cancer of Ovary
| Article | Year |
|---|---|
Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Colorectal Neoplasms; Enzyme Inhibitors; Female; Hemangioma; Humans; Hydroxamic Acids; Melanoma; Metalloendopeptidases; Mice; Ovarian Neoplasms; Pancreatic Neoplasms; Phenylalanine; Protease Inhibitors; Skin Neoplasms; Thiophenes | 1997 |
[Cytostatic treatment of ovarian carcinoma].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hydroxamic Acids; Ovarian Neoplasms; Paclitaxel; Protease Inhibitors; Trastuzumab | 1999 |
2 other study(ies) available for marimastat and Cancer of Ovary
| Article | Year |
|---|---|
Tumour marker levels during marimastat therapy.
Topics: CA-125 Antigen; Enzyme Inhibitors; Female; Humans; Hydroxamic Acids; Metalloendopeptidases; Ovarian Neoplasms; Retrospective Studies | 1996 |
Marimastat. BB 2516, TA 2516.
Topics: Adult; Antineoplastic Agents; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Hydroxamic Acids; Male; Melanoma; Metalloendopeptidases; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Protease Inhibitors; Stomach Neoplasms | 1999 |